-
Willow Biosciences Q1 FY23 Revenue Grows To $203K, Still In Development Stage And On 'A Solid Trajectory'
Friday, May 12, 2023 - 10:17am | 581Willow Biosciences Inc. (OTCQB: CANSF) (TSX:WLLW) released its financial and operating results for the three months ended March 31, 2023, revealing revenue of CA$274,000 ($203,000) compared to no revenue in Q1 2022. The company is in the development stage and expects to operate at a loss and...